We found that the SMARCA4R1157W mutant increased the binding access to PRMT1-mediated H4R3me2a and enhanced ATPase activity and chromatin remodeling activities, thereby reinforcing EGFR and TNS4 expression and accelerating the progression of CRC. This evidence concerns the gene PRMT1 and colorectal carcinoma.